Seventieth World Health Assembly

Provisional agenda

12.
Preparedness, surveillance and response
12.1
Health emergencies
12.1.1
The Independent Oversight and Advisory Committee for the WHO Health Emergencies Programme
12.1.2
WHO response in severe, large-scale emergencies
12.1.3
Research and development for potentially epidemic diseases
12.1.4
Health workforce coordination in emergencies with health consequences
12.2
Antimicrobial resistance
12.3
Poliomyelitis
12.4
Implementation of the International Health Regulations (2005)
12.5
Review of the Pandemic Influenza Preparedness Framework
13.
Health systems
13.1
Human resources for health and implementation of the outcomes of the United Nations’ High-Level Commission on Health Employment and Economic Growth
13.2
Principles on the donation and management of blood, blood components and other medical products of human origin
13.3
Addressing the global shortage of, and access to, medicines and vaccines
13.4
Evaluation and review of the global strategy and plan of action on public health, innovation and intellectual property
13.5
Follow-up of the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination
13.6
Member State mechanism on substandard/spurious/falsely-labelled/falsified/counterfeit medical products
13.7
Promoting the health of refugees and migrants
14.
Communicable diseases
14.1
Global vaccine action plan
14.2
Global vector control response
15.
Noncommunicable diseases
15.1
Preparation for the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases, to be held in 2018
15.2
Draft global action plan on the public health response to dementia
15.3
Public health dimension of the world drug problem
15.4
Outcome of the Second International Conference on Nutrition
15.5
Report of the Commission on Ending Childhood Obesity: implementation plan
15.6
Cancer prevention and control in the context of an integrated approach
15.7
Strengthening synergies between the World Health Assembly and the Conference of the Parties to the WHO Framework Convention on Tobacco Control
15.8
Prevention of deafness and hearing loss
16.
Promoting health through the life course
16.1
Progress in the implementation of the 2030 Agenda for Sustainable Development
16.2
The role of the health sector in the Strategic Approach to International Chemicals Management towards the 2020 goal and beyond
16.3
Global Strategy for Women’s, Children’s and Adolescents’ Health (2016–2030): adolescents’ health
17.
Progress reports
17.1
Noncommunicable diseases
17.1.1
A. WHO global disability action plan 2014–2021: better health for all people with disability (resolution WHA67.7 (2014))
17.1.2
B. Addressing the challenges of the United Nations Decade of Action for Road Safety (2011–2020): outcome of the second Global High-level Conference on Road Safety – Time for Results (resolution WHA69.7 (2016))
17.1.3
C. Towards universal eye health: a global action plan 2014–2019 (resolution WHA66.4 (2013))
17.2
Communicable diseases
17.2.1
D. Eradication of dracunculiasis (resolution WHA64.16 (2011))
17.2.2
E. Global strategy and targets for tuberculosis prevention, care and control after 2015 (resolution WHA67.1 (2014))
17.2.3
F. Global technical strategy and targets for malaria 2016–2030 (resolution WHA68.2 (2015))
17.3
Promoting health through the life course
17.3.1
G. Public health impacts of exposure to mercury and mercury compounds: the role of WHO and ministries of public health in the implementation of the Minamata Convention (resolution WHA67.11 (2014))
17.3.2
H. Strategy for integrating gender analysis and actions into the work of WHO (resolution WHA60.25 (2007))
17.4
Health systems
17.4.1
I. Progress in the rational use of medicines (resolution WHA60.16 (2007))
17.4.2
J. Regulatory system strengthening for medical products (resolution WHA67.20 (2014))
17.4.3
K. Strengthening emergency and essential surgical care and anaesthesia as a component of universal health coverage (resolution WHA68.15 (2015))
17.5
Preparedness, surveillance and response
17.5.1
L. Smallpox eradication: destruction of variola virus stocks (resolution WHA60.1 (2007))
17.5.2
M. Enhancement of laboratory biosafety (resolution WHA58.29 (2005))
23.
Management, legal and governance matters
23.3
Engagement with non-State actors